We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go: Expired investment: £165,627
Redwell Brewing is a small batch independent brewery offering an entire range which is audited gluten-free and certified vegan. Well known for its handmade beer, the brewery’s booming taproom and events space which opened in 2018 on a shoestring budget of £200 is also a well-loved destination with sales of £30,000 in December 2018 alone. The brewery has partnered with several retailers and wholesalers, including creating an own-label craft beer for ALDI. With focus on flavours and community, Redwell Brewing is constantly innovating and winning awards, such as three GOLDs in the World Beer Awards. With the proceeds, it's planning to expand its facilities and its range into on and off trading outlets beyond the UK. 
days to go: Expired investment: £75,650
Cheran's Bakery, based in Kent, specializes in crafting sumptuous sweet treats available online and at their expanding chain of five stores. With sales exceeding £1.2 million since inception, they create indulgent and creatively packaged products, baked daily for maximum freshness and luxury. Their high-quality, visually appealing shop designs and 'Instagrammable' offerings have attracted over 24,000 social media followers, amplifying brand recognition, while their focus on delivering exceptional customer experiences fosters word-of-mouth promotion.
days to go: Expired investment: £325,482
Derby Brewing Co is a family-run business which currently has 4 award winning venues, all reflecting individuality. With 4 sites, serving their established range of real ales, locally sourced home cooked food and one of the sites its own boutique hotel, they will be using the funds to launch a new site and a new range of craft beers. The family business is growing and generated a revenue of £3,000,000 last year.
days to go: Expired investment: £545,000
The Cookaway is a Direct-to-Consumer (DTC) company that makes and sells recipe boxes to users to enable them to make delicious food from the comfort of their homes. Users receive all the ingredients, including premium oils, along with complete recipe cards made by the company's expert chefs. The Cookaway has garnered over 500 verified reviews on TrustPilot with an 'Excellent' rating and onboarded 10 chefs including 5 MasterChefs and a 2-Michelin starred chef. It has featured in publications such as The Independent, Forbes, The Week, and The Daily Mail. The company was the 'Chosen Food Partner' for The Lord Mayor's Big Curry Lunch 2021. The Cookaway will use 25% of the investment to hire talent, 20% to boost brand visibility via content generation, 15% to make its technology platform more intuitive, 15% to launch new chefs and cuisines, 5% to improve its sustainability credentials, 5% to develop its app with more features, 10% towards automation, and 5% to launch a membership program.

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £792,187
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph